Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor × Hydroxychloroquine × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 2 Breast 1

Conditions

Breast Neoplasms 7 Solid Tumor 1 Peripheral Nervous System Diseases 1 Neoplasm, Residual 1 Hypoxia 1 Estrogen Receptor Positive Breast Cancer 1 Breast Neoplasms, Male 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

abemaciclib 1 Letrozole 1 Hydroxychloroquine 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04316169 2022-12-23

Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer

Medical College of Wisconsin

Phase 1 Withdrawn

BreastOther solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡